← Open Payments lookup

RYAN KATIDES: Open Payments

NPI 1093315863 · BOSTON, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$4,717 in 16 payments from 10 companies in 2025. Trend: 2023 $1,031 · 2024 $437 · 2025 $4,717

Speaker / faculty: $3,563Consulting: $750Food & beverage: $404
CompanyPaymentsAmount
Bayer Healthcare Pharmaceuticals Inc.3$3,687
AstraZeneca Pharmaceuticals LP1$750
Astellas Pharma US Inc5$107
Janssen Biotech, Inc.1$46
E.R. Squibb & Sons, L.L.C.1$25
Caris MPI, Inc.1$25
BeOne Medicines USA, Inc.1$23
Lilly USA, LLC1$20
Novocure Inc.1$18
Novartis Pharmaceuticals Corporation1$17

Products named: Nubeqa, LYNPARZA, Xtandi, TECVAYLI, OPDIVO, MI CANCER SEEK, BRUKINSA, Fabhalta.

Industry payments across MA — which companies pay providers there.